경직장초음파 전립선침생검: 시술 전 관장의 유효성 = Transrectal Needle Biopsy of the Prostate: The Efficacy of a Pre-biopsy Enema

다국어 초록 (Multilingual Abstract)

Purpose: There are numerous biopsy protocols that have been described in the clinical literature. We especially assess the role of the use of an enema before a transrectal prostate biopsy by comparing the post biopsy- infectious complications rate.
Materials and Methods: From January 2007 to August 2007 we retrospectively evaluated 302 men who underwent transrectal needle biopsy of the prostate according to the inclusion criteria. Patients in group 1(121 patients) did not receive an enema and were given oral ciprofloxacin(500 mg) for 3 days. Those in group 2(181 patients) received an enema before the biopsy and were also administered intravenous ciprofloxacin(400mg) and an additional oral form(500mg) for five days. Only complications related to infection were evaluated, that is, fever and chills with systemic inflammatory symptoms, within two weeks after the biopsy.
Results: Patients demographics, such as age and prostate size did not differ between the two groups(p＞0.05), but the level of prostate-specific antigen (PSA) in group 2 was significantly higher than in group 1 (12.70ng/ml versus 28.88ng/ml, p＜0.05). The cancer detection rate was 36.1%(109/ 302) overall and there was no significant difference between the two groups(32.2% versus 38.7%, p＞0.05). The infectious complications rate was 2.6%(8/302) overall and did not differ significantly between the two groups(2.5% versus 2.8%, p＞0.05). Especially for group 2 patients, there were two cases of bacteremia and Escherichia coli was reported as the pathogen.
Conclusions: Our findings suggest that the use of a pre-biopsy enema shows no significant benefit given the considerations of infectious complications rate, and the patient quality of life. (Korean J Urol 2008;49:248-251)

다국어 초록 (Multilingual Abstract)

Purpose: There are numerous biopsy protocols that have been described in the clinical literature. We especially assess the role of the use of an enema before a transrectal prostate biopsy by comparing the post biopsy- infectious complications rate.
Materials and Methods: From January 2007 to August 2007 we retrospectively evaluated 302 men who underwent transrectal needle biopsy of the prostate according to the inclusion criteria. Patients in group 1(121 patients) did not receive an enema and were given oral ciprofloxacin(500 mg) for 3 days. Those in group 2(181 patients) received an enema before the biopsy and were also administered intravenous ciprofloxacin(400mg) and an additional oral form(500mg) for five days. Only complications related to infection were evaluated, that is, fever and chills with systemic inflammatory symptoms, within two weeks after the biopsy.
Results: Patients demographics, such as age and prostate size did not differ between the two groups(p＞0.05), but the level of prostate-specific antigen (PSA) in group 2 was significantly higher than in group 1 (12.70ng/ml versus 28.88ng/ml, p＜0.05). The cancer detection rate was 36.1%(109/ 302) overall and there was no significant difference between the two groups(32.2% versus 38.7%, p＞0.05). The infectious complications rate was 2.6%(8/302) overall and did not differ significantly between the two groups(2.5% versus 2.8%, p＞0.05). Especially for group 2 patients, there were two cases of bacteremia and Escherichia coli was reported as the pathogen.
Conclusions: Our findings suggest that the use of a pre-biopsy enema shows no significant benefit given the considerations of infectious complications rate, and the patient quality of life. (Korean J Urol 2008;49:248-251)

참고문헌 (Reference)

1 Ramey JR, "Ultrasonography and biopsy of the prostate" Campbell-Walsh urology. 9th ed 2883-2895, 2007

2 Carey JM, "Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications?" 166 : 82-85, 2001

3 Kim TB, "The effectiveness of 12 core biopsy protocol according to prostate-specific antigen(PSA) level and prostate v" 47 : 1166-1171, 2006

4 Vallancien G, "Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination" 146 : 1308-1312, 1991

5 Griffith BC, "Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk" 168 : 1021-1023, 2002

6 Djavan B, "Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study" 166 : 856-860, 2001

7 Rodriguez LV, "Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature" 160 : 2115-2120, 1998

8 Desmond PM, "Morbidity with contemporary prostate biopsy" 150 : 1425-1426, 1993

9 Tal R, "Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy" 169 : 1762-1765, 2003

10 Byun SS, "Effect of periprostatic nerve blockade for transrectal ultrasound guided biopsy of the prostate" 45 : 663-666, 2004

11 Carter HB, "Diagnosis and staging of prostate cancer" Campbell-Walsh urology. 9th ed. 2912-2932, 2007

12 Rietbergen JB, "Complications of transrectal ultrasound guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program" 49 : 875-880, 1997

13 Hwang KH, "Complications and success rate of transrectal systematic sextant biopsy of the prostate under the finger guidance" 36 : 1231-1237, 1995

14 Raaijamakers R, "Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program" 60 : 826-830, 2002

15 Lindert KA, "Bacteremia and bacteriuria after transrectal ultrasound guided prostate biopsy" 164 : 76-80, 2000

16 Cormio L, "Antimicrobial prophylaxis for transrectal prostatic biosy: a prospective study of ciprofloxacin vs piperacillin/tazobactam" 90 : 700-702, 2002

17 Sieber PR, "Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy" 157 : 2199-2200, 1997

18 Aron M, "Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study" 85 : 682-685, 2000

19 Brown RW, "Alford RH. Bacteremia and bacteriuria after transrectal prostatic biopsy" 18 : 145-148, 1981